Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience

Raphael Hagmann; Viviane Hess; Alfred Zippelius; Sacha I. Rothschild

doi:10.7150/jca.13080

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience

Journal of Cancer ◽

10.7150/jca.13080 ◽

2015 ◽

Vol 6 (11) ◽

pp. 1148-1154 ◽

Cited By ~ 12

Author(s):

Raphael Hagmann ◽

Viviane Hess ◽

Alfred Zippelius ◽

Sacha I. Rothschild

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Combination Treatment ◽

Small Cell ◽

Second Line ◽

Single Center ◽

Small Cell Lung ◽

Second Line Therapy ◽

Single Center Experience ◽

Line Therapy

Download Full-text

Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer: Results from the Phase 3 TAHOE Study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.02.009 ◽

2021 ◽

Author(s):

Fiona Blackhall ◽

Kevin Jao ◽

Laurent Greillier ◽

Byoung Chul Cho ◽

Konstantin Penkov ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Second Line Therapy ◽

Phase 3 ◽

Line Therapy

Download Full-text

Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study

Current Medical Research and Opinion ◽

10.1185/03007995.2012.703133 ◽

2012 ◽

Vol 28 (8) ◽

pp. 1253-1262 ◽

Cited By ~ 7

Author(s):

Alain Vergnenegre ◽

Egbert F. Smit ◽

Elisabeth Toy ◽

Barbara Parente ◽

Stephan Schmitz ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Practice ◽

Observational Study ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Treatment Pathways ◽

Line Therapy

Download Full-text

Second-line therapy of squamous non-small cell lung cancer: an evolving landscape

Expert Review of Respiratory Medicine ◽

10.1080/17476348.2017.1326822 ◽

2017 ◽

Vol 11 (6) ◽

pp. 469-479 ◽

Cited By ~ 7

Author(s):

Chiara Lazzari ◽

Niki Karachaliou ◽

Vanesa Gregorc ◽

Alessandra Bulotta ◽

Maria Gonzalez-Cao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy

Download Full-text

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.01.008 ◽

2019 ◽

Vol 14 (5) ◽

pp. 903-913 ◽

Cited By ~ 38

Author(s):

Jean-Louis Pujol ◽

Laurent Greillier ◽

Clarisse Audigier-Valette ◽

Denis Moro-Sibilot ◽

Lionel Uwer ◽

...

Keyword(s):

Lung Cancer ◽

Cell Death ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy

Download Full-text

A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC)

Tumor Biology ◽

10.1007/s13277-016-5031-0 ◽

2016 ◽

Vol 37 (8) ◽

pp. 11479-11484 ◽

Cited By ~ 2

Author(s):

Rencui Quan ◽

Jiaxing Huang ◽

Nan Chen ◽

Wenfeng Fang ◽

Zhihuang Hu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy

Download Full-text

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer

Investigational New Drugs ◽

10.1007/s10637-005-0754-6 ◽

2005 ◽

Vol 23 (6) ◽

pp. 563-567 ◽

Cited By ~ 6

Author(s):

Afshin Dowlati ◽

Robert Chapman ◽

Shanmuga Subbiah ◽

Pingfu Fu ◽

Anne Ness ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

9121 POSTER A Multi-center, Open, Randomized, Phase II Study to Investigate the Sequential Administration of Docetaxel and Intermittent Erlotinib Versus Erlotinib as a Second-line Therapy for Advanced Non-small Cell Lung Cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(11)72433-9 ◽

2011 ◽

Vol 47 ◽

pp. S630

Author(s):

F. Aparisi ◽

A. Sánchez ◽

V. Giner ◽

J. Mufioz ◽

G. Esquerdo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii ◽

Sequential Administration

Download Full-text

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options

Future Oncology ◽

10.2217/fon-2016-0493 ◽

2017 ◽

Vol 13 (13) ◽

pp. 1159-1171 ◽

Cited By ~ 7

Author(s):

Sanjay Popat ◽

Anders Mellemgaard ◽

Martin Reck ◽

Claudia Hastedt ◽

Ingolf Griebsch

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Therapeutic Options ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy

Download Full-text

Second-Line Therapy for Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.3816/clc.2009.n.011 ◽

2009 ◽

Vol 10 (2) ◽

pp. 91-98 ◽

Cited By ~ 4

Author(s):

Belisario A. Arango ◽

Aurelio B. Castrellon ◽

Edgardo S. Santos ◽

Luis E. Raez

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy

Download Full-text

Does second-line therapy for non-small cell lung cancer (NSCLC) result in symptom palliation? Analysis of 484 patients from a randomized trial of pemetrexed vs docetaxel

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7035 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7035-7035 ◽

Cited By ~ 5

Author(s):

F. De Marinis ◽

J. R. Pereira ◽

K. Park ◽

S. S. Leong ◽

C.-M. Tsai ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Second Line Therapy ◽

Line Therapy ◽

Symptom Palliation

Download Full-text